Anthony @ Equity Investigations, Dear Anthony, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:45:00 AM
From: TripleT	Read Replies (1) of 122087

Anthony, no one can say for certain. However, I've served on government review boards before and can say that they like to have all their questions answered and can be very obstinate if the applicant balks. The FDA panel rejected the SNRS data because of two reasons 1. The test results are really dismal if you look at some of the statistics. The regression is just a company smokescreen to cover up the fact that the doctors set out for "some improvement" vrs "correct the eyesight". Hence the slide that stated "properly managed expectation". Believe it or not, it was there on the SNRS website. It as well as all the potentially damaging pages were removed by the company. 2. The company did not provide the test data as requested by the panel. I'm not currently short the stock. Any tips on how to play this thing if the application fails? Shorting is going to impossible Friday morning and I've read that the stock will be stopped Thursday because of the review. Thanks in advance TTT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next